| |
07/21/2008 |
 |
AlphaVax Announces Initiation of Chlamydia Vaccine Program
click here >>
|
06/06/2008 |
|
AlphaVax Continues to Expand the Use of its Vaccine Platform
click here >>
|
04/17/2008 |
|
AlphaVax Announces Initial Analysis of Data from CMV Phase 1 Clinical Trial
click here >>
|
01/30/2008 |
|
AlphaVax Announces New CMV Advisory Board
click here >>
|
10/31/2007 |
|
AlphaVax Announces Results from Phase 1 Influenza Vaccine Clinical Trial
click here >>
|
07/30/2007 |
|
AlphaVax Announces Interim Results from Phase 1 Influenza Vaccine Clinical Trial
click here >>
|
07/10/2007 |
|
AlphaVax Announces $3.6M Award to Develop New Adjuvant Technologies for Vaccines
click here >>
|
04/11/2007 |
|
AlphaVax begins Clinical Trials with Vaccines for CMV and FLU
click here >>
|
02/19/2007 |
|
New Data Support AlphaVax's Vaccine for CMV
click here >>
|
02/02/2007 |
|
AlphaVax Announces the Closing of its E Series Investment Offering
click here >>
|
01/29/2007 |
|
AlphaVax Announces Clinical Trials for Influenza and CMV
click here >>
|
09/06/2006 |
|
AlphaVax Announces Phase 1 Clinical Trial Results
click here >>
|
07/26/2006 |
|
AlphaVax Granted Key Vaccine Manufacturing Patent in US
click here >>
|
05/10/2006 |
|
Three NCBIO members serving on National BIO Committees
click here >>
|
04/05/2006 |
|
Peter Young to Testify on BioShield
click here >>
|
11/11/2005 |
|
The Triangle’s Fastest Growing Private Biotech Company
click here >>
|
10/21/2005 |
|
Alphavax Announces Support of Senator Richard Burr's Legislation
click here >>
|
10/19/2005 |
|
Alphavax Announces $3.3 Million Grant Award to Develop A Smallpox Vaccine
click here >>
|
06/03/2005 |
|
AlphaVax Announces New Lease for Vaccine Manufacturing Operations
click here >>
|
05/01/2005 |
|
Peter Young elected Chair of NCBIO
click here >>
|
04/10/2005 |
|
AlphaVax Annouces NIH Award for Influenza Vaccine
click here >>
|
02/06/2005 |
|
Gene Vaccine Protects Mice Against Development of Her2/neu Breast Cancer
click here >>
|
11/17/2004 |
|
AlphaVax Annouces $4.8m Award for a SARS Vaccine
click here >>
|
06/04/2004 |
|
AlphaVax Annouces New Vice President of Development
click here >>
|
03/25/2004 |
|
AlphaVax Annouces New Manufacturing Initiative
click here >>
|